Document Detail


Effect of caffeic acid phenethyl ester on gastric acid secretion in vitro.
MedLine Citation:
PMID:  16183057     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Caffeic acid phenethyl ester (CAPE), one of the major components of propolis (honeybee resin), has demonstrated a wide spectrum of activities including suppression of eicosanoids by inhibition of cyclooxygenase-1 and cyclooxygenase-2 enzyme activities. The aim of this study was to investigate the effect of CAPE on basal and secretagogues-stimulated gastric acid secretion in vitro. In the isolated, lumen-perfused, stomach preparation of mouse, CAPE (10-100 microM) did not affect the basal gastric acid secretion nor the secretion stimulated by histamine, pentagastrin, isobutyl methylxanthine and high levels of K+. By contrast, CAPE increased the gastric acid secretion induced by the muscarinic receptor agonist, 5-methylfurmethide (5-MEF). CAPE also inhibited the acetylcholinesterase activity in an in vitro colorimetric assay. Eserine (10 microM), a well known acetylcholinesterase inhibitor, also increased 5-MEF-stimulated acid secretion. Our results show that CAPE increases gastric acid secretion stimulated by an acetylcholine agonist receptor likely through inhibition of acetylcholinesterase activity.
Authors:
Francesca Borrelli; Inmaculada Posadas; Raffaele Capasso; Gabriella Aviello; Valeria Ascione; Francesco Capasso
Related Documents :
8238517 - Trh in dorsal vagal complex mediates acid response to excitation of raphe pallidus neur...
314297 - Inhibitory effect of cimetidine, an antagonist of histamine h2-receptor, on gastric aci...
2909437 - Splanchnic nerve activation inhibits the increase in duodenal hco3- secretion induced b...
8449557 - Ocimum sanctum linn--a study on gastric ulceration and gastric secretion in rats.
8238517 - Trh in dorsal vagal complex mediates acid response to excitation of raphe pallidus neur...
22821947 - Dipeptidyl peptidase iv inhibition potentiates amino acid- and bile acid-induced bicarb...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't     Date:  2005-09-23
Journal Detail:
Title:  European journal of pharmacology     Volume:  521     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-10-11     Completed Date:  2006-01-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  139-43     Citation Subset:  IM    
Affiliation:
Department of Experimental Pharmacology, University of Naples Federico II, Via D. Montesano 49, 80131, Naples, Italy. franborr@unina.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Methyl-3-isobutylxanthine / pharmacology
Acetylcholinesterase / metabolism
Animals
Caffeic Acids / pharmacology*
Cholinesterase Inhibitors / pharmacology
Dose-Response Relationship, Drug
Gastric Acid / secretion*
Gastrointestinal Agents / pharmacology
Histamine / pharmacology
Male
Mice
Mice, Inbred ICR
Muscarine / analogs & derivatives,  pharmacology
Nifedipine / pharmacology
Pentagastrin / pharmacology
Phenylethyl Alcohol / analogs & derivatives*,  pharmacology
Physostigmine / pharmacology
Potassium / pharmacology
Stomach / drug effects*,  metabolism
Chemical
Reg. No./Substance:
0/Caffeic Acids; 0/Cholinesterase Inhibitors; 0/Gastrointestinal Agents; 104594-70-9/caffeic acid phenethyl ester; 14172-53-3/5-methylfurtrethonium; 21829-25-4/Nifedipine; 28822-58-4/1-Methyl-3-isobutylxanthine; 300-54-9/Muscarine; 51-45-6/Histamine; 5534-95-2/Pentagastrin; 57-47-6/Physostigmine; 60-12-8/Phenylethyl Alcohol; 7440-09-7/Potassium; EC 3.1.1.7/Acetylcholinesterase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antidystonic efficacy of gamma-aminobutyric acid uptake inhibitors in the dtsz mutant.
Next Document:  Reduction of myocardial infarct size by SM-197378, a novel Na+/H+ exchange inhibitor, in rabbits.